Sign in
MNKD Stock Price, Chart, Stats & News
MannKind Corporation
Save
1.21B
Market cap
–
Current P/E
41.32x
Forward P/E
MNKD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 76.39% |
Operating margin | 11.08% |
Pretax margin | 0.40% |
Net margin | 1.68% |
Effective tax rate | -316.70% |
ROA | 0.74% |
ROE | -11.21% |
D/E | -9.28x |
Interest coverage ratio | 1.04x |
MNKD valuation
P/E | – |
P/S | 2.01x |
P/B | -13.66x |
P/CF | 38.50x |
P/FCF | 51.90x |
P/OCF | 38.50x |
PEG | -1.49x |
EV multiple | 5.85x |
About
MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U. S. market.
Similar securities
Based on sector and market capitalization
Report issue